KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Tax Provisions (2018 - 2025)

Castle Biosciences' Tax Provisions history spans 7 years, with the latest figure at -$371000.0 for Q4 2025.

  • For Q4 2025, Tax Provisions rose 78.24% year-over-year to -$371000.0; the TTM value through Dec 2025 reached -$5.4 million, down 261.37%, while the annual FY2025 figure was -$5.4 million, 261.37% down from the prior year.
  • Tax Provisions for Q4 2025 was -$371000.0 at Castle Biosciences, down from $115000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $6.0 million in Q3 2024 and bottomed at -$4.7 million in Q2 2025.
  • The 5-year median for Tax Provisions is $14000.0 (2023), against an average of -$321823.5.
  • The largest annual shift saw Tax Provisions crashed 39240.0% in 2022 before it surged 18690.62% in 2024.
  • A 5-year view of Tax Provisions shows it stood at -$1.8 million in 2021, then soared by 103.21% to $57000.0 in 2022, then crashed by 31.58% to $39000.0 in 2023, then crashed by 4471.79% to -$1.7 million in 2024, then soared by 78.24% to -$371000.0 in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Tax Provisions are -$371000.0 (Q4 2025), $115000.0 (Q3 2025), and -$4.7 million (Q2 2025).